International Lymphoma Epidemiology
Consortium
The InterLymph Consortium, or formally the International Consortium
of Investigators Working on Non-Hodgkin's Lymphoma Epidemiologic Studies,
is an open scientific forum for epidemiologic research in non-Hodgkin's
lymphoma. Formed in 2001, the Consortium is a group of international investigators
who have completed or have ongoing case-control studies and who discuss
and undertake research projects that pool data across studies or otherwise
undertake collaborative research.
The InterLymph researchers meet annually.
The 2008 meeting will be in Sydney, Australia, on July 29-31. In addition, there will be an optional extra one-day scientific symposium on risk factors for lymphoma on July 28. (These dates are two weeks later than previously proposed.)
For information contact Annelie Landgren, NCI’s Division of Cancer Epidemiology
and Genetics (DCEG).
Five working groups develop ideas for coordinated
research.
Support for logistical needs of the Consortium is provided by NCI's Division
of Cancer Epidemiology and Genetics (DCEG), which is the intramural
(in house) research component of the Institute, and the Epidemiology
and Genetics Research Program (EGRP) of the Division of Cancer
Control and Population Sciences (DCCPS), which manages the epidemiology
grant program for the Institute, Bethesda, Maryland; the International
Agency for Research on Cancer (IARC), Lyon, France; and the Leukaemia
Research Fund, London, England. Some investigators within
the Consortium also have grant support for research projects
through EGRP.
NCI Contacts
Martha Linet, M.D., M.P.H., Radiation Epidemiology Branch, Division
of Cancer Epidemiology and Genetics, NCI
Carol Kasten, M.D., Epidemiology
and Genetics Research Program, DCCPS, NCI
|
